JPRN-UMIN000017538招募中2 期
Phase II study of pegfilgrastim as support to metastatic pancreatic cancer patients receiving FOLFIRINOX - Phase II study of pegfilgrastim as support to metastatic pancreatic cancer patients receiving FOLFIRINOX
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Prior radiotherapy or chemotherapy 2)Grade 2 or greater peripheral neuropathy 3)Blood transfusion, administration of blood products, or hematopoietic (e.g., G-CSF) support within 7 days before enrollment 4)UGT genetic polymorphisms of homozygous UGT1A1*6 or UGT1A1*28 or heterozygous UGT1A1*6 and *28 5)confirm the presence of ascites or peritoneal metastasis by imaging 6)Intestinal pneumonitis or pulmonary fibrosis 7)severe diarrhea within 3 days before enrollment 8)Clinically significant heart disease 9)Active infection (except HBV+,HCV+) 10)Poor glycemic control diabetes mellitus 11)Serious complications (organ failure, or active peptic ulcer etc) 12)Severe mental disorder, or central nervous system disorders 13)Serious drug allergy 14)Active double cancer 15)Brain or meningeal metastasis 16)Pregnancy 17)Treatment with atazanavir sulfate 18)Inappropriate for this study judged by the investigator
研究者
相似试验
已完成
2 期
Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast CancerStage I Breast CancerStage II Breast CancerBreast CancerNCT00146562Harold J. Burstein, MD, PhD135
尚未招募
3 期
Comparison of the effect of pegfilgrastim with filgrastim on the neutrophil count of cancer patients under chemotherapy.IRCT20180119038433N3Semnan University of Medical Sciences60
进行中（未招募）
不适用
PEG-Filgrastim versus Filgrastim as an adjunct to therapy CHOP-14 Rituximab in elderly patients 60-75 years old with B cell non-Hodgkin s High/intermediate grade lymphoma. A randomized, prospectic, multicenter, open-label, phase II study.Maintenance of dose-intensityMedDRA version: 6.1Level: HLGTClassification code 10025320EUCTR2005-004646-13-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI50
已完成
2 期
The comparison of effects of two drugs in neutropenic patientseutropenia.NeutropeniaIRCT201205279875N1Cinnagen Drug Corporation66
已完成
4 期
FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive ChemotherapyNeutropeniaNCT00125723Amgen2,252